The European Oncology Regulatory Newsletter has launched its first edition, targeting those interested in cancer medicines. This monthly publication will provide updates on the latest scientific opinions, regulatory initiatives, events, and activities related to oncology medicines within the EU. The online version includes automatic translations in all EU languages for accessibility.

Key details:

  • First edition available: EU Regulatory Oncology Newsletter – October 2024.
  • Subscription: Readers can subscribe to receive monthly editions directly via the Newsroom Subscription Form.

The newsletter aims to serve as a valuable resource for staying informed about developments in oncology regulation across Europe.1

Read more here.

References

  1. EU Regulatory Oncology Newsletter – October 2024. (n.d.). https://ec.europa.eu/newsroom/ema/newsletter-archives/56965

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred